Abstract
The SARS-CoV-2 B.1.1.7 variant that was first identified in Kent (UK) in December, 2020, has now spread to many countries and shown consistent fitness advantage over other variants in circulation at the time.1 This means an increase in transmission potential, which alone can lead to increased rates of hospitalisations and deaths. In The Lancet Infectious Diseases, Peter Bager and colleagues report the risk of hospitalisation with B.1.1.7 variant using the impressive population-level sequencing data in Denmark that include cases detected from both community-based and hospital-based testing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
